

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.84914280 |
| 2 | response to peptidoglycan (GO:0032494) | 4.19993270 |
| 3 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.10290076 |
| 4 | protein localization to endosome (GO:0036010) | 3.75901801 |
| 5 | apoptotic process involved in morphogenesis (GO:0060561) | 3.66871654 |
| 6 | pentose-phosphate shunt (GO:0006098) | 3.52042846 |
| 7 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.50675214 |
| 8 | regulation of early endosome to late endosome transport (GO:2000641) | 3.49070848 |
| 9 | ribosomal small subunit biogenesis (GO:0042274) | 3.46898373 |
| 10 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.46281582 |
| 11 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.45894579 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.41828927 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.41828927 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.41828927 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 3.41828927 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.41828927 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 3.41828927 |
| 18 | modulation by symbiont of host cellular process (GO:0044068) | 3.38891382 |
| 19 | mannose metabolic process (GO:0006013) | 3.26941257 |
| 20 | modulation by virus of host process (GO:0019054) | 3.26437461 |
| 21 | pinocytosis (GO:0006907) | 3.23783672 |
| 22 | maternal placenta development (GO:0001893) | 3.18526566 |
| 23 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.08322166 |
| 24 | glucose catabolic process (GO:0006007) | 3.04904509 |
| 25 | activation of Rac GTPase activity (GO:0032863) | 3.01499000 |
| 26 | NIK/NF-kappaB signaling (GO:0038061) | 2.98364335 |
| 27 | activation of MAPKKK activity (GO:0000185) | 2.98339486 |
| 28 | NADPH regeneration (GO:0006740) | 2.95242611 |
| 29 | cellular response to virus (GO:0098586) | 2.94376066 |
| 30 | response to muramyl dipeptide (GO:0032495) | 2.92557455 |
| 31 | glucose 6-phosphate metabolic process (GO:0051156) | 2.91870435 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90014041 |
| 33 | negative regulation of cell size (GO:0045792) | 2.80706191 |
| 34 | adherens junction assembly (GO:0034333) | 2.80212625 |
| 35 | focal adhesion assembly (GO:0048041) | 2.78590410 |
| 36 | cell-substrate adherens junction assembly (GO:0007045) | 2.78590410 |
| 37 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.77718579 |
| 38 | embryonic process involved in female pregnancy (GO:0060136) | 2.77650929 |
| 39 | proline biosynthetic process (GO:0006561) | 2.76041547 |
| 40 | negative regulation of viral release from host cell (GO:1902187) | 2.75483174 |
| 41 | stress fiber assembly (GO:0043149) | 2.74033018 |
| 42 | response to laminar fluid shear stress (GO:0034616) | 2.71236876 |
| 43 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.71189152 |
| 44 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.70917269 |
| 45 | regulation of superoxide anion generation (GO:0032928) | 2.70420917 |
| 46 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.70287247 |
| 47 | detection of other organism (GO:0098543) | 2.68481229 |
| 48 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.68461609 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 2.67943974 |
| 50 | pentose metabolic process (GO:0019321) | 2.67595282 |
| 51 | detection of bacterium (GO:0016045) | 2.65978517 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 2.64000654 |
| 53 | positive regulation of histone deacetylation (GO:0031065) | 2.63561581 |
| 54 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60940857 |
| 55 | viral transcription (GO:0019083) | 2.60603488 |
| 56 | regulation of leukocyte degranulation (GO:0043300) | 2.59464666 |
| 57 | barbed-end actin filament capping (GO:0051016) | 2.58037364 |
| 58 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.57681749 |
| 59 | regulation of chromatin binding (GO:0035561) | 2.57108452 |
| 60 | heterochromatin organization (GO:0070828) | 2.55581215 |
| 61 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.54117735 |
| 62 | cell-cell junction maintenance (GO:0045217) | 2.52668414 |
| 63 | negative regulation of necroptotic process (GO:0060546) | 2.51906558 |
| 64 | regulation of necrotic cell death (GO:0010939) | 2.44233651 |
| 65 | mRNA stabilization (GO:0048255) | 2.43298230 |
| 66 | RNA stabilization (GO:0043489) | 2.43298230 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 2.43195110 |
| 68 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.39861297 |
| 69 | protein retention in ER lumen (GO:0006621) | 2.37549207 |
| 70 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.37543967 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.37223390 |
| 72 | negative regulation of fatty acid transport (GO:2000192) | 2.34890239 |
| 73 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.34748003 |
| 74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.33912879 |
| 75 | regulation of mast cell degranulation (GO:0043304) | 2.33339598 |
| 76 | glycosphingolipid catabolic process (GO:0046479) | 2.33246368 |
| 77 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.32566083 |
| 78 | apoptotic process involved in development (GO:1902742) | 2.32043803 |
| 79 | modulation by virus of host morphology or physiology (GO:0019048) | 2.31365386 |
| 80 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.30829870 |
| 81 | negative regulation of cell killing (GO:0031342) | 2.29994668 |
| 82 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.29994668 |
| 83 | regulation of necroptotic process (GO:0060544) | 2.29872878 |
| 84 | detection of external biotic stimulus (GO:0098581) | 2.28635834 |
| 85 | low-density lipoprotein particle clearance (GO:0034383) | 2.26780585 |
| 86 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.24895441 |
| 87 | response to host (GO:0075136) | 2.24895441 |
| 88 | response to host defenses (GO:0052200) | 2.24895441 |
| 89 | germinal center formation (GO:0002467) | 2.24232013 |
| 90 | leukocyte aggregation (GO:0070486) | 2.23106637 |
| 91 | positive regulation of protein deacetylation (GO:0090312) | 2.21254548 |
| 92 | COPI coating of Golgi vesicle (GO:0048205) | 2.20562100 |
| 93 | Golgi transport vesicle coating (GO:0048200) | 2.20562100 |
| 94 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.20456920 |
| 95 | translational termination (GO:0006415) | 2.20070546 |
| 96 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.19929638 |
| 97 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.19761728 |
| 98 | response to host immune response (GO:0052572) | 2.19493018 |
| 99 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.19493018 |
| 100 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.18973456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.28609180 |
| 2 | * MYC_22102868_ChIP-Seq_BL_Human | 2.93779761 |
| 3 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.68558731 |
| 4 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.47704466 |
| 5 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40559621 |
| 6 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.36908716 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.35137789 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.30215728 |
| 9 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.27459799 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.26829405 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.23710743 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.21857633 |
| 13 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.12861335 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.10845706 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07090237 |
| 16 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.05430511 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.03861491 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.03752773 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90073413 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89440279 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84094636 |
| 22 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.63565120 |
| 23 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62704739 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60267444 |
| 25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58661268 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.58073300 |
| 27 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.56753979 |
| 28 | P68_20966046_ChIP-Seq_HELA_Human | 1.54007562 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.48456372 |
| 30 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47490241 |
| 31 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.47369412 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46984247 |
| 33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45500512 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42706537 |
| 35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.41971237 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.40901772 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39877464 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39679610 |
| 39 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39553529 |
| 40 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38446517 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37218268 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36863651 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36047653 |
| 44 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34996731 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34754538 |
| 46 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34522620 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.32062841 |
| 48 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31808492 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29109234 |
| 50 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27631092 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26472807 |
| 52 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23479159 |
| 53 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23425026 |
| 54 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23030170 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22970943 |
| 56 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22438795 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.22415244 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21580340 |
| 59 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21189042 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20762323 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20218057 |
| 62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19927991 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19474624 |
| 64 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19308623 |
| 65 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.18731296 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18227870 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18120691 |
| 68 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15557117 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15338715 |
| 70 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.15117802 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15034844 |
| 72 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.14148878 |
| 73 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13679432 |
| 74 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13028043 |
| 75 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12650501 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11941823 |
| 77 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.11685858 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11524464 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10873807 |
| 80 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.10419292 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08383719 |
| 82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.08317249 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08268794 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07836964 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07019426 |
| 86 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06623681 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06300017 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05224973 |
| 89 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05224593 |
| 90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.04535537 |
| 91 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.04515993 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04011642 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03959826 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03740436 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02340076 |
| 96 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02202243 |
| 97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00657826 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99621976 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99392614 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98650122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.95224075 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.55478254 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.31018489 |
| 4 | MP0003303_peritoneal_inflammation | 3.24985772 |
| 5 | MP0005076_abnormal_cell_differentiation | 2.82545117 |
| 6 | MP0003436_decreased_susceptibility_to | 2.78421632 |
| 7 | MP0009840_abnormal_foam_cell | 2.65619816 |
| 8 | MP0009278_abnormal_bone_marrow | 2.50326572 |
| 9 | MP0008260_abnormal_autophagy | 2.42148334 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.41799264 |
| 11 | MP0004858_abnormal_nervous_system | 2.11495131 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.03424823 |
| 13 | MP0003172_abnormal_lysosome_physiology | 1.97922815 |
| 14 | MP0003453_abnormal_keratinocyte_physiol | 1.97623025 |
| 15 | MP0004510_myositis | 1.94829659 |
| 16 | MP0001849_ear_inflammation | 1.93693103 |
| 17 | MP0003300_gastrointestinal_ulcer | 1.93316870 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 1.89309177 |
| 19 | MP0000858_altered_metastatic_potential | 1.73421418 |
| 20 | MP0004947_skin_inflammation | 1.67714747 |
| 21 | MP0002419_abnormal_innate_immunity | 1.63480685 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 1.60834096 |
| 23 | MP0000678_abnormal_parathyroid_gland | 1.59733709 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.58586185 |
| 25 | MP0005025_abnormal_response_to | 1.58191864 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.52678341 |
| 27 | MP0000685_abnormal_immune_system | 1.44305659 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 1.44041257 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.41698850 |
| 30 | MP0009379_abnormal_foot_pigmentation | 1.31794552 |
| 31 | MP0002249_abnormal_larynx_morphology | 1.31229420 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.31045709 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.28315634 |
| 34 | MP0002796_impaired_skin_barrier | 1.25611924 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.25439716 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.24766980 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.24746849 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.24746849 |
| 39 | MP0009785_altered_susceptibility_to | 1.23231500 |
| 40 | MP0003091_abnormal_cell_migration | 1.22530960 |
| 41 | MP0002089_abnormal_postnatal_growth/wei | 1.22460572 |
| 42 | MP0000490_abnormal_crypts_of | 1.21736200 |
| 43 | MP0005387_immune_system_phenotype | 1.21270734 |
| 44 | MP0001790_abnormal_immune_system | 1.21270734 |
| 45 | MP0005375_adipose_tissue_phenotype | 1.20793950 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.20483950 |
| 47 | MP0000750_abnormal_muscle_regeneration | 1.20141887 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.19005993 |
| 49 | MP0003075_altered_response_to | 1.17038382 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.15392625 |
| 51 | MP0003123_paternal_imprinting | 1.15116848 |
| 52 | MP0001819_abnormal_immune_cell | 1.13696903 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.13385555 |
| 54 | MP0002723_abnormal_immune_serum | 1.13313220 |
| 55 | MP0000747_muscle_weakness | 1.12500542 |
| 56 | MP0005409_darkened_coat_color | 1.12141958 |
| 57 | MP0004233_abnormal_muscle_weight | 1.11548290 |
| 58 | MP0001835_abnormal_antigen_presentation | 1.11473171 |
| 59 | MP0005501_abnormal_skin_physiology | 1.09103122 |
| 60 | MP0000733_abnormal_muscle_development | 1.08827374 |
| 61 | MP0003828_pulmonary_edema | 1.07158724 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.05691487 |
| 63 | MP0000343_altered_response_to | 1.05352655 |
| 64 | MP0002398_abnormal_bone_marrow | 1.03957436 |
| 65 | MP0001800_abnormal_humoral_immune | 1.03288087 |
| 66 | MP0001730_embryonic_growth_arrest | 1.03101216 |
| 67 | MP0000537_abnormal_urethra_morphology | 1.02363119 |
| 68 | MP0001853_heart_inflammation | 1.01617533 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.01189138 |
| 70 | MP0002254_reproductive_system_inflammat | 1.00200305 |
| 71 | MP0000716_abnormal_immune_system | 0.95013098 |
| 72 | MP0002429_abnormal_blood_cell | 0.94307964 |
| 73 | MP0001845_abnormal_inflammatory_respons | 0.93547713 |
| 74 | MP0009672_abnormal_birth_weight | 0.93215521 |
| 75 | MP0002405_respiratory_system_inflammati | 0.91198438 |
| 76 | MP0002722_abnormal_immune_system | 0.89591570 |
| 77 | MP0001873_stomach_inflammation | 0.89147673 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.86838815 |
| 79 | MP0008469_abnormal_protein_level | 0.86059576 |
| 80 | MP0005023_abnormal_wound_healing | 0.85970827 |
| 81 | MP0010030_abnormal_orbit_morphology | 0.85661874 |
| 82 | MP0002132_abnormal_respiratory_system | 0.84699897 |
| 83 | MP0003111_abnormal_nucleus_morphology | 0.83182443 |
| 84 | MP0002139_abnormal_hepatobiliary_system | 0.83039487 |
| 85 | MP0003724_increased_susceptibility_to | 0.82947932 |
| 86 | MP0003329_amyloid_beta_deposits | 0.82856853 |
| 87 | MP0000759_abnormal_skeletal_muscle | 0.82723941 |
| 88 | MP0009931_abnormal_skin_appearance | 0.82586039 |
| 89 | MP0005257_abnormal_intraocular_pressure | 0.82584222 |
| 90 | MP0010630_abnormal_cardiac_muscle | 0.80177866 |
| 91 | MP0000604_amyloidosis | 0.79921176 |
| 92 | MP0005621_abnormal_cell_physiology | 0.79537391 |
| 93 | MP0006082_CNS_inflammation | 0.79157330 |
| 94 | MP0005390_skeleton_phenotype | 0.78009564 |
| 95 | MP0000313_abnormal_cell_death | 0.76356994 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.74749833 |
| 97 | MP0003279_aneurysm | 0.74218400 |
| 98 | MP0001915_intracranial_hemorrhage | 0.73459441 |
| 99 | MP0000681_abnormal_thyroid_gland | 0.73155019 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.73121377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.21818499 |
| 2 | Achilles tendon contracture (HP:0001771) | 3.15202048 |
| 3 | Distal lower limb amyotrophy (HP:0008944) | 3.00009874 |
| 4 | Hyperacusis (HP:0010780) | 2.94206013 |
| 5 | Distal lower limb muscle weakness (HP:0009053) | 2.93147055 |
| 6 | Increased connective tissue (HP:0009025) | 2.91600456 |
| 7 | Abnormality of the Achilles tendon (HP:0005109) | 2.88396003 |
| 8 | Abnormality of macrophages (HP:0004311) | 2.87445515 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 2.75486568 |
| 10 | Cellulitis (HP:0100658) | 2.75002090 |
| 11 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.72944274 |
| 12 | Recurrent abscess formation (HP:0002722) | 2.69481399 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 2.62661689 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53735144 |
| 15 | Obstructive lung disease (HP:0006536) | 2.53735144 |
| 16 | Ulnar bowing (HP:0003031) | 2.53559489 |
| 17 | Vertebral compression fractures (HP:0002953) | 2.47257132 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43164293 |
| 19 | Myopathic facies (HP:0002058) | 2.37349770 |
| 20 | Polygenic inheritance (HP:0010982) | 2.36008705 |
| 21 | Broad face (HP:0000283) | 2.33579069 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.28085045 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.28085045 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 2.28085045 |
| 25 | Abnormality of the thoracic spine (HP:0100711) | 2.27531121 |
| 26 | Bulbar palsy (HP:0001283) | 2.26183108 |
| 27 | Disproportionate tall stature (HP:0001519) | 2.21565757 |
| 28 | Colitis (HP:0002583) | 2.20519650 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 2.19121207 |
| 30 | Stridor (HP:0010307) | 2.18735188 |
| 31 | Thoracic kyphosis (HP:0002942) | 2.18323468 |
| 32 | Increased serum ferritin (HP:0003281) | 2.17104715 |
| 33 | Long palpebral fissure (HP:0000637) | 2.14747003 |
| 34 | Deep venous thrombosis (HP:0002625) | 2.13402170 |
| 35 | Progressive muscle weakness (HP:0003323) | 2.13197381 |
| 36 | Axonal loss (HP:0003447) | 2.12936984 |
| 37 | Obstructive sleep apnea (HP:0002870) | 2.10665126 |
| 38 | Broad distal phalanx of finger (HP:0009836) | 2.10593616 |
| 39 | Hypertensive crisis (HP:0100735) | 2.10285458 |
| 40 | Hemorrhage of the eye (HP:0011885) | 2.10116312 |
| 41 | Difficulty climbing stairs (HP:0003551) | 2.09692145 |
| 42 | Flat acetabular roof (HP:0003180) | 2.07145190 |
| 43 | Thin bony cortex (HP:0002753) | 2.06852093 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.06017311 |
| 45 | Reticulocytosis (HP:0001923) | 2.04881460 |
| 46 | Gingivitis (HP:0000230) | 2.04244756 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03562017 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02831345 |
| 49 | Increased variability in muscle fiber diameter (HP:0003557) | 2.01563149 |
| 50 | Loss of speech (HP:0002371) | 1.99051892 |
| 51 | Cerebral aneurysm (HP:0004944) | 1.97568153 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97505176 |
| 53 | Hypertriglyceridemia (HP:0002155) | 1.91031755 |
| 54 | Distal upper limb amyotrophy (HP:0007149) | 1.90865251 |
| 55 | Upper limb amyotrophy (HP:0009129) | 1.90865251 |
| 56 | Ragged-red muscle fibers (HP:0003200) | 1.90497307 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 1.87835439 |
| 58 | Deep palmar crease (HP:0006191) | 1.86624075 |
| 59 | Cholecystitis (HP:0001082) | 1.85533242 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 1.85533242 |
| 61 | Short nail (HP:0001799) | 1.84070785 |
| 62 | Myocardial infarction (HP:0001658) | 1.83822484 |
| 63 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83117203 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 1.82751817 |
| 65 | Increased IgE level (HP:0003212) | 1.82241637 |
| 66 | Lower limb amyotrophy (HP:0007210) | 1.81555046 |
| 67 | Upper motor neuron abnormality (HP:0002127) | 1.79809251 |
| 68 | Purpura (HP:0000979) | 1.79675548 |
| 69 | Easy fatigability (HP:0003388) | 1.76924839 |
| 70 | Mitral regurgitation (HP:0001653) | 1.76538012 |
| 71 | Pathologic fracture (HP:0002756) | 1.76442328 |
| 72 | Trismus (HP:0000211) | 1.75514618 |
| 73 | Bone pain (HP:0002653) | 1.75059467 |
| 74 | Generalized amyotrophy (HP:0003700) | 1.74608635 |
| 75 | Fragile skin (HP:0001030) | 1.73870569 |
| 76 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.72618405 |
| 77 | Protrusio acetabuli (HP:0003179) | 1.70886326 |
| 78 | Nuclear cataract (HP:0100018) | 1.69047832 |
| 79 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.68533901 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.67904567 |
| 81 | Diaphragmatic weakness (HP:0009113) | 1.67847140 |
| 82 | Polycythemia (HP:0001901) | 1.67503136 |
| 83 | Abnormality of reticulocytes (HP:0004312) | 1.67391401 |
| 84 | Hyperparathyroidism (HP:0000843) | 1.66461328 |
| 85 | Myositis (HP:0100614) | 1.63973163 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 1.63812141 |
| 87 | Exercise-induced myalgia (HP:0003738) | 1.60719869 |
| 88 | Interstitial pulmonary disease (HP:0006530) | 1.60715681 |
| 89 | Petechiae (HP:0000967) | 1.60547898 |
| 90 | Truncus arteriosus (HP:0001660) | 1.59106535 |
| 91 | Metaphyseal cupping (HP:0003021) | 1.58717390 |
| 92 | Gastrointestinal stroma tumor (HP:0100723) | 1.58244694 |
| 93 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.58233764 |
| 94 | J-shaped sella turcica (HP:0002680) | 1.58102084 |
| 95 | Genu recurvatum (HP:0002816) | 1.58044481 |
| 96 | Meningitis (HP:0001287) | 1.57592473 |
| 97 | Abnormal vertebral ossification (HP:0100569) | 1.56706033 |
| 98 | Inflammation of the large intestine (HP:0002037) | 1.55517414 |
| 99 | Blue sclerae (HP:0000592) | 1.55003008 |
| 100 | Premature rupture of membranes (HP:0001788) | 1.54983860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.92728533 |
| 2 | SMG1 | 3.65336005 |
| 3 | IRAK3 | 3.64312420 |
| 4 | PRPF4B | 3.34322726 |
| 5 | NME2 | 3.11264226 |
| 6 | ERN1 | 2.97524534 |
| 7 | SIK1 | 2.92044019 |
| 8 | ICK | 2.39187767 |
| 9 | MAP2K3 | 2.13691781 |
| 10 | EEF2K | 2.04225639 |
| 11 | MAP3K11 | 2.03462412 |
| 12 | TAOK2 | 1.90805692 |
| 13 | MAP3K10 | 1.87778808 |
| 14 | IRAK4 | 1.86240305 |
| 15 | TTN | 1.84123723 |
| 16 | EPHA2 | 1.73040490 |
| 17 | MAP4K1 | 1.72698722 |
| 18 | CDK12 | 1.55982285 |
| 19 | TAOK1 | 1.53907014 |
| 20 | IRAK2 | 1.48834321 |
| 21 | RIPK1 | 1.45325934 |
| 22 | RIPK4 | 1.39021436 |
| 23 | MAP3K3 | 1.35509954 |
| 24 | PKN2 | 1.30827165 |
| 25 | ARAF | 1.24714811 |
| 26 | TBK1 | 1.19173407 |
| 27 | BRAF | 1.18030046 |
| 28 | PTK6 | 1.17928069 |
| 29 | MAP3K1 | 1.16942193 |
| 30 | FGFR4 | 1.12695206 |
| 31 | EPHB1 | 1.12202932 |
| 32 | PAK4 | 1.10425411 |
| 33 | MAP3K13 | 1.06092406 |
| 34 | MARK2 | 1.03391489 |
| 35 | TESK2 | 1.01526545 |
| 36 | PDPK1 | 0.93570504 |
| 37 | MST1R | 0.92640596 |
| 38 | MAP3K8 | 0.90091276 |
| 39 | PRKD2 | 0.89864409 |
| 40 | MTOR | 0.89261203 |
| 41 | TYK2 | 0.88383419 |
| 42 | RPS6KC1 | 0.86171957 |
| 43 | RPS6KL1 | 0.86171957 |
| 44 | BMX | 0.85026261 |
| 45 | CDC42BPA | 0.84407736 |
| 46 | LRRK2 | 0.82376065 |
| 47 | MAP2K2 | 0.82047979 |
| 48 | CSK | 0.80491121 |
| 49 | KSR2 | 0.79959529 |
| 50 | RPS6KA2 | 0.79584937 |
| 51 | LMTK2 | 0.78934800 |
| 52 | BLK | 0.78433711 |
| 53 | RPS6KB2 | 0.78371850 |
| 54 | HIPK2 | 0.76742912 |
| 55 | MAP3K14 | 0.71985499 |
| 56 | ZAP70 | 0.71617194 |
| 57 | GRK6 | 0.71357902 |
| 58 | TESK1 | 0.70133072 |
| 59 | CDK4 | 0.69337647 |
| 60 | TNK2 | 0.68671552 |
| 61 | PIM2 | 0.68277800 |
| 62 | PRKG2 | 0.67923648 |
| 63 | ILK | 0.65079325 |
| 64 | MAPK11 | 0.62196946 |
| 65 | RPS6KA6 | 0.61967536 |
| 66 | BTK | 0.61267626 |
| 67 | CAMK1D | 0.57551533 |
| 68 | PDGFRA | 0.55177673 |
| 69 | DMPK | 0.55060588 |
| 70 | MOS | 0.54937732 |
| 71 | PTK2 | 0.53600096 |
| 72 | MATK | 0.53480461 |
| 73 | IRAK1 | 0.53474936 |
| 74 | CDK7 | 0.51998615 |
| 75 | LATS2 | 0.51682179 |
| 76 | IKBKB | 0.50938542 |
| 77 | DDR2 | 0.50613140 |
| 78 | PRKD3 | 0.50407178 |
| 79 | PDK1 | 0.50011651 |
| 80 | JAK3 | 0.47382932 |
| 81 | MAPK12 | 0.46766019 |
| 82 | DAPK3 | 0.45609324 |
| 83 | SIK2 | 0.45064837 |
| 84 | DYRK1B | 0.45063927 |
| 85 | ABL2 | 0.45003251 |
| 86 | RPS6KA1 | 0.44937722 |
| 87 | VRK2 | 0.44915377 |
| 88 | SIK3 | 0.43877162 |
| 89 | DYRK3 | 0.43098215 |
| 90 | KDR | 0.41860604 |
| 91 | FES | 0.40777511 |
| 92 | FGR | 0.40445179 |
| 93 | AURKA | 0.39861200 |
| 94 | MAP3K6 | 0.39725973 |
| 95 | HCK | 0.37709206 |
| 96 | CSF1R | 0.36701643 |
| 97 | MAPKAPK2 | 0.35740417 |
| 98 | IKBKE | 0.35448867 |
| 99 | CHUK | 0.33014123 |
| 100 | EPHB2 | 0.32493789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.89742978 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.53657904 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.50238084 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.36602057 |
| 5 | Bladder cancer_Homo sapiens_hsa05219 | 2.07654701 |
| 6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.07230358 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97908894 |
| 8 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.92310103 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.91888416 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 1.87384756 |
| 11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.83481295 |
| 12 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.76674102 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76135935 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66325214 |
| 15 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.66229632 |
| 16 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.65741687 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53597436 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51417964 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.51043434 |
| 20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.49289593 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.47445719 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37670028 |
| 23 | Thyroid cancer_Homo sapiens_hsa05216 | 1.36000554 |
| 24 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26583331 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25685005 |
| 26 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.24419854 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.24138643 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.19617149 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.19462315 |
| 30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.17492309 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.16770077 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16166921 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.14878156 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.14481753 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.14046027 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12045995 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.10471824 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08950549 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.06090302 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04606472 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.04288332 |
| 42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03480929 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02813925 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02354091 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01191225 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00983634 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.00180576 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99834328 |
| 49 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94361807 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94064605 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93808685 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92460163 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89186530 |
| 54 | Glioma_Homo sapiens_hsa05214 | 0.87404897 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87131141 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86686347 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85484976 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82984269 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.82252625 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.80534519 |
| 61 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80321052 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78306872 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77606583 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76258826 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75014984 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74041425 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73862123 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73498176 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.73011440 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71804194 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.71784697 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71463465 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70636532 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69220219 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.68933653 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68102570 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68053438 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65727721 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64911614 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.64534246 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.64296991 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63270690 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62182362 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61601921 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60271336 |
| 86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56721916 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56137998 |
| 88 | DNA replication_Homo sapiens_hsa03030 | 0.55661129 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55352141 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55155292 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54343715 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.53086727 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52701314 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51731866 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51299354 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49610664 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49541089 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.49033168 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46288045 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46008251 |

